Status:
COMPLETED
Role of EUS in Detection of Liver Metastasis
Lead Sponsor:
Mahmoud Wahba
Conditions:
Liver Metastases
Pancreatic Neoplasms
Eligibility:
All Genders
12-75 years
Brief Summary
Liver metastasis may not be detected by CT and MRI due to their small size while they can be detected by EUS. Also, EUS-FNA has a great impact in improving the diagnostic accuracy of EUS. Objectives: ...
Detailed Description
Endoscopic ultrasound (EUS) was used firstly in 1980s as a diagnostic imaging technique for pancreatic lesions. It has the ability to detect the histological layers of the gastrointestinal (GI) tract ...
Eligibility Criteria
Inclusion
- All patients diagnosed with either pancreatic or gastrointestinal tumors and have undergone a CT scan of the abdomen with contrast or MRI before being referred for EUS for staging
Exclusion
- Patients are younger than 12 years. Patients who previously known to have HCC. Patient unfit for deep sedation by Propofol injection. Patients with bleeding disorders contraindicating EUS-FNA
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 21 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04509492
Start Date
October 1 2020
End Date
April 21 2021
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12613